tiprankstipranks
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
Holding ANIP?
Track your performance easily

ANI Pharmaceuticals (ANIP) Financial Statements

289 Followers

ANI Pharmaceuticals Financial Overview

ANI Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.541; its P/E ratio is -98.47; ANI Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $1.45. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 148.33M$ 138.04M$ 137.43M$ -38.78M$ 131.83M
Gross Profit$ 69.51M$ 65.64M$ 88.27M$ -49.47M$ 83.73M
EBIT$ -29.17M$ 2.37M$ 29.93M$ -76.07M$ 17.91M
EBITDA$ -10.20M$ 17.07M$ 44.62M$ -61.02M$ 33.12M
Net Income Common Stockholders$ -24.17M$ -2.69M$ 17.80M$ -78.78M$ 9.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 144.98M$ 240.11M$ 228.60M$ 221.12M$ 193.08M
Total Assets$ 1.29B$ 920.75M$ 914.52M$ 1.02B$ 889.91M
Total Debt$ 625.36M$ 285.24M$ 285.46M$ 284.82M$ 285.88M
Net Debt$ 480.38M$ 45.13M$ 56.86M$ 63.70M$ 92.80M
Total Liabilities$ 856.58M$ 440.14M$ 437.71M$ 421.99M$ 435.20M
Stockholders Equity$ 430.80M$ 480.61M$ 476.81M$ 442.83M$ 454.71M
Cash Flow-
Free Cash Flow$ 7.03M$ 12.96M$ 27.20M$ 42.77M$ 27.62M
Operating Cash Flow$ 12.47M$ 17.41M$ 18.27M$ 44.74M$ 32.17M
Investing Cash Flow$ -398.52M$ -4.45M$ 8.93M$ -4.78M$ -4.55M
Financing Cash Flow$ 291.03M$ -1.45M$ -19.73M$ -11.92M$ 3.75M
Currency in USD

ANI Pharmaceuticals Earnings and Revenue History

ANI Pharmaceuticals Debt to Assets

ANI Pharmaceuticals Cash Flow

ANI Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis